We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Sets out the government's quality standards for diabetes services.
A meta-analysis of randomized controlled trials
This study aims to identify the reasons for not undergoing confirmation by those at high risk for developing diabetes
A Randomised Controlled Trial in a Nigerian Tertiary Care Hospital
For the first time in the UK, obese patients and people who are overweight with weight-related health problems could now have access to Mounjaro, currently used for Type 2 diabetes, to help manage their weight and support weight loss.
How to optimise the NHS Diabetes Prevention Programme in order to identify those at risk of Type 2 diabetes and help lower their risk of developing the disease.
Synthesises lessons and successful approaches from research in Pakistan, China, Bangladesh, Nigeria and Swaziland
The new presentation of Mounjaro gives four doses for once-a-week treatment over a month.
This study assessed diabetic care services at public health facilities across 6 districts in 3 states of India
Advice for medical professionals to follow when assessing drivers with diabetes mellitus.
Employment Tribunal decision.
This workbook was developed by the Health Inequalities National Support Teams (HINST) with 70 local authorities covering populations in England.
Effects of cash transfers on health-seeking behaviour, service use, and clinical outcomes among Syrian refugees with type II diabetes in Jordan
The DOVE tool shows the relationship between spending on diabetes care and clinical outcomes in GP and clinical commissioning group (CCG) areas.
This policy brief make 5 recommendations to address health systems challenges for diabetes care in Pakistan
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).